AI Bias Analysis
4 models · Takes ~15 seconds
How a rare disease drugmaker won FDA approval after a clinical trial disappointed.
Source
Stat News
Opens original article in a new tab
RFK Jr.'s testimony to Congress, broader access to peptides, and more health news from Morning Rounds
Roche is launching a Phase 3 trial of the controversial Duchenne gene therapy Elevidys, hoping it could lead to approval in Europe.
RFK Jr. has a delicate task ahead of him as he faces a marathon of hearings on Capitol Hill.
The debate about AI and mental health has so far focused on content. But the way the content is delivered matters, too.
